Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Other financing activities (2020 - 2025)

Sight Sciences has reported Other financing activities over the past 6 years, most recently at -$10.5 million for Q4 2025.

  • Quarterly results put Other financing activities at -$10.5 million for Q4 2025, down 366.22% from a year ago — trailing twelve months through Dec 2025 was -$4.2 million (down 133.13% YoY), and the annual figure for FY2024 was $17.1 million, up 17.12%.
  • Other financing activities for Q4 2025 was -$10.5 million at Sight Sciences, down from $2.4 million in the prior quarter.
  • Over the last five years, Other financing activities for SGHT hit a ceiling of $14.6 million in Q4 2023 and a floor of -$10.5 million in Q4 2025.
  • Median Other financing activities over the past 5 years was $3.2 million (2022), compared with a mean of $2.8 million.
  • Biggest five-year swings in Other financing activities: soared 1332.31% in 2021 and later tumbled 366.22% in 2025.
  • Sight Sciences' Other financing activities stood at $2.0 million in 2021, then skyrocketed by 63.66% to $3.2 million in 2022, then skyrocketed by 350.87% to $14.6 million in 2023, then crashed by 72.94% to $3.9 million in 2024, then tumbled by 366.22% to -$10.5 million in 2025.
  • The last three reported values for Other financing activities were -$10.5 million (Q4 2025), $2.4 million (Q3 2025), and $3.8 million (Q2 2025) per Business Quant data.